Detection of antibody that binds to water soluble polymer-modified polypeptides
    1.
    发明授权
    Detection of antibody that binds to water soluble polymer-modified polypeptides 有权
    检测结合水溶性聚合物修饰多肽的抗体

    公开(公告)号:US08216793B2

    公开(公告)日:2012-07-10

    申请号:US12786641

    申请日:2010-05-25

    IPC分类号: G01N33/566

    CPC分类号: G01N33/6854

    摘要: The present invention provides analytical methods for detecting anti-polymer antibody in an individual. The methods involve contacting a sample from the individual with a water soluble polymer-modified carrier and detecting binding of antibody to the water soluble polymer on the water soluble polymer-modified carrier wherein binding is indicative of the presence of antibody to the water polymer-modified polypeptide. Antibody may be detected to water soluble polymers such as polyethylene glycol, polysialic acid, dextran, hydroxyalkyl starch, or hydroxyethyl starch. When antibody to the water soluble polymer polyethylene glycol is to be detected, the carrier is modified with a non-linear polyethylene glycol derivative.

    摘要翻译: 本发明提供了检测个体抗体抗体的分析方法。 所述方法包括使来自个体的样品与水溶性聚合物修饰的载体接触并检测抗体与水溶性聚合物修饰的载体上的水溶性聚合物的结合,其中结合指示抗体存在于聚合物修饰的水 多肽。 可以对水溶性聚合物如聚乙二醇,聚唾液酸,葡聚糖,羟烷基淀粉或羟乙基淀粉检测抗体。 当检测到对水溶性聚合物聚乙二醇的抗体时,用非线性聚乙二醇衍生物修饰载体。

    DETECTION OF ANTIBODY THAT BINDS TO WATER SOLUBLE POLYMER-MODIFIED POLYPEPTIDES
    2.
    发明申请
    DETECTION OF ANTIBODY THAT BINDS TO WATER SOLUBLE POLYMER-MODIFIED POLYPEPTIDES 审中-公开
    检测抗水溶性聚合物改性多糖的抗体

    公开(公告)号:US20120309021A1

    公开(公告)日:2012-12-06

    申请号:US13489925

    申请日:2012-06-06

    IPC分类号: G01N33/566 G01N33/573

    CPC分类号: G01N33/6854

    摘要: The present invention provides analytical methods for detecting anti-polymer antibody in an individual. The methods involve contacting a sample from the individual with a water soluble polymer-modified carrier and detecting binding of antibody to the water soluble polymer on the water soluble polymer-modified carrier wherein binding is indicative of the presence of antibody to the water polymer-modified polypeptide. Antibody may be detected to water soluble polymers such as polyethylene glycol, polysialic acid, dextran, hydroxyalkyl starch, or hydroxyethyl starch. When antibody to the water soluble polymer polyethylene glycol is to be detected, the carrier is modified with a non-linear polyethylene glycol derivative.

    摘要翻译: 本发明提供了检测个体抗体抗体的分析方法。 所述方法包括使来自个体的样品与水溶性聚合物修饰的载体接触并检测抗体与水溶性聚合物修饰的载体上的水溶性聚合物的结合,其中结合指示抗体存在于聚合物修饰的水 多肽。 可以对水溶性聚合物如聚乙二醇,聚唾液酸,葡聚糖,羟烷基淀粉或羟乙基淀粉检测抗体。 当检测到对水溶性聚合物聚乙二醇的抗体时,用非线性聚乙二醇衍生物修饰载体。

    DETECTION OF ANTIBODY THAT BINDS TO WATER SOLUBLE POLYMER-MODIFIED POLYPEPTIDES
    3.
    发明申请
    DETECTION OF ANTIBODY THAT BINDS TO WATER SOLUBLE POLYMER-MODIFIED POLYPEPTIDES 有权
    检测抗水溶性聚合物改性多糖的抗体

    公开(公告)号:US20110070592A1

    公开(公告)日:2011-03-24

    申请号:US12786641

    申请日:2010-05-25

    IPC分类号: G01N33/566

    CPC分类号: G01N33/6854

    摘要: The present invention provides analytical methods for detecting anti-polymer antibody in an individual. The methods involve contacting a sample from the individual with a water soluble polymer-modified carrier and detecting binding of antibody to the water soluble polymer on the water soluble polymer-modified carrier wherein binding is indicative of the presence of antibody to the water polymer-modified polypeptide. Antibody may be detected to water soluble polymers such as polyethylene glycol, polysialic acid, dextran, hydroxyalkyl starch, or hydroxyethyl starch. When antibody to the water soluble polymer polyethylene glycol is to be detected, the carrier is modified with a non-linear polyethylene glycol derivative.

    摘要翻译: 本发明提供了检测个体抗体抗体的分析方法。 所述方法包括使来自个体的样品与水溶性聚合物修饰的载体接触并检测抗体与水溶性聚合物修饰的载体上的水溶性聚合物的结合,其中结合指示抗体存在于聚合物修饰的水 多肽。 可以对水溶性聚合物如聚乙二醇,聚唾液酸,葡聚糖,羟烷基淀粉或羟乙基淀粉检测抗体。 当检测到对水溶性聚合物聚乙二醇的抗体时,用非线性聚乙二醇衍生物修饰载体。

    Stable preparation for the treatment of blood coagulation disorders
    5.
    发明授权
    Stable preparation for the treatment of blood coagulation disorders 失效
    稳定的治疗凝血障碍的准备

    公开(公告)号:US6017891A

    公开(公告)日:2000-01-25

    申请号:US924533

    申请日:1997-09-05

    CPC分类号: B82Y5/00 C12N9/6424 C12N9/96

    摘要: The invention relates to a stable preparation which comprises a protein, such as thrombin, that is bound in and/or on (i.e., to) lipid vesicles and that was treated for the inactivation of potentially present viruses. Further, the invention relates to methods for the production of a stable preparation for the treatment of blood coagulation disorders, wherein a protein is bound in and/or on lipid vesicles, and the method comprises a step in which the protein lipid complex is subjected to a treatment for the inactivation of potentially present viruses.

    摘要翻译: 本发明涉及一种稳定的制剂,其包含结合于脂质囊泡中和/或上(即)脂质囊泡上的蛋白质,例如凝血酶,并且被处理用于灭活潜在的存在的病毒。 此外,本发明涉及生产用于治疗凝血障碍的稳定制剂的方法,其中蛋白质与脂质囊泡中和/或结合,该方法包括将蛋白质脂质复合物经受 用于灭活潜在存在的病毒的治疗。

    Polymer-von Willebrand factor-conjugates

    公开(公告)号:US08076463B2

    公开(公告)日:2011-12-13

    申请号:US13007208

    申请日:2011-01-14

    IPC分类号: C12P21/02 C07K14/47 A61K38/37

    摘要: The present invention relates to a proteinaceous construct (also designated as polymer-VWF-conjugate) comprising plasmatic and/or recombinant von Willebrand factor (VWF), said VWF being bound to at least one physiologically acceptable polymer molecule, as well as to a complex between said proteinaceous construct and at least one factor VIII (FVIII) protein. The physiologically acceptable polymer molecule can be, for instance, polyethylene glycol (PEG) or polysialic acid (PSA). Further the present invention relates to methods for prolonging the in vivo-half-life of VWF or FVIII in the blood of a mammal having a bleeding disorder associated with functional defects of or deficiencies of at least one of FVIII or VWF.